The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Drugs for Anti-Infective Market Research Report 2024
Synopsis
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The global Drugs for Anti-Infective market was valued at US$ 215340 million in 2023 and is anticipated to reach US$ 272130 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Drugs for Anti-Infective, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Anti-Infective.
Report Scope
The Drugs for Anti-Infective market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Anti-Infective market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Anti-Infective companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Anti-Infective companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Something capable of acting against infection, by inhibiting the spread of an infectious agent or by killing the infectious agent outright. Anti-infective is a general term that encompasses antibacterials, antibiotics, antifungals, antiprotozoans and antivirals.
The global Drugs for Anti-Infective market was valued at US$ 215340 million in 2023 and is anticipated to reach US$ 272130 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
The Anti-Infective Drugs market refers to the pharmaceuticals and medications used for the treatment of infectious diseases caused by bacteria, viruses, fungi, or parasites. This market encompasses various therapeutic areas such as antibiotics, antivirals, antifungals, and antiparasitics. The Anti-Infective Drugs market has been witnessing steady growth due to factors such as the increasing prevalence of infectious diseases, the emergence of drug-resistant strains, and the growing global population. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, but the market in Asia Pacific is expected to witness substantial growth in the coming years.
This report aims to provide a comprehensive presentation of the global market for Drugs for Anti-Infective, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Anti-Infective.
Report Scope
The Drugs for Anti-Infective market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Anti-Infective market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drugs for Anti-Infective companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Merck
Pfizer
Novartis AG
Gilead Sciences
Abbott
Sanofi-Aventis
Bristol-Myers Squibb
Johnson
Roche Pharma AG
Nanosphere
NanoViricides
Novabay Pharmaceuticals
Obetech
Optimer Pharmaceuticals
Basilea Pharmaceutica AG
Daiichi Sankyo
Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drugs for Anti-Infective companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drugs for Anti-Infective Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Drugs for Anti-Infective Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drugs for Anti-Infective Market Perspective (2019-2030)
2.2 Drugs for Anti-Infective Growth Trends by Region
2.2.1 Global Drugs for Anti-Infective Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Drugs for Anti-Infective Historic Market Size by Region (2019-2024)
2.2.3 Drugs for Anti-Infective Forecasted Market Size by Region (2025-2030)
2.3 Drugs for Anti-Infective Market Dynamics
2.3.1 Drugs for Anti-Infective Industry Trends
2.3.2 Drugs for Anti-Infective Market Drivers
2.3.3 Drugs for Anti-Infective Market Challenges
2.3.4 Drugs for Anti-Infective Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drugs for Anti-Infective Players by Revenue
3.1.1 Global Top Drugs for Anti-Infective Players by Revenue (2019-2024)
3.1.2 Global Drugs for Anti-Infective Revenue Market Share by Players (2019-2024)
3.2 Global Drugs for Anti-Infective Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drugs for Anti-Infective Revenue
3.4 Global Drugs for Anti-Infective Market Concentration Ratio
3.4.1 Global Drugs for Anti-Infective Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drugs for Anti-Infective Revenue in 2023
3.5 Drugs for Anti-Infective Key Players Head office and Area Served
3.6 Key Players Drugs for Anti-Infective Product Solution and Service
3.7 Date of Enter into Drugs for Anti-Infective Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drugs for Anti-Infective Breakdown Data by Type
4.1 Global Drugs for Anti-Infective Historic Market Size by Type (2019-2024)
4.2 Global Drugs for Anti-Infective Forecasted Market Size by Type (2025-2030)
5 Drugs for Anti-Infective Breakdown Data by Application
5.1 Global Drugs for Anti-Infective Historic Market Size by Application (2019-2024)
5.2 Global Drugs for Anti-Infective Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Drugs for Anti-Infective Market Size (2019-2030)
6.2 North America Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Drugs for Anti-Infective Market Size by Country (2019-2024)
6.4 North America Drugs for Anti-Infective Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drugs for Anti-Infective Market Size (2019-2030)
7.2 Europe Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Drugs for Anti-Infective Market Size by Country (2019-2024)
7.4 Europe Drugs for Anti-Infective Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drugs for Anti-Infective Market Size (2019-2030)
8.2 Asia-Pacific Drugs for Anti-Infective Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Drugs for Anti-Infective Market Size by Region (2019-2024)
8.4 Asia-Pacific Drugs for Anti-Infective Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drugs for Anti-Infective Market Size (2019-2030)
9.2 Latin America Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Drugs for Anti-Infective Market Size by Country (2019-2024)
9.4 Latin America Drugs for Anti-Infective Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drugs for Anti-Infective Market Size (2019-2030)
10.2 Middle East & Africa Drugs for Anti-Infective Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Drugs for Anti-Infective Market Size by Country (2019-2024)
10.4 Middle East & Africa Drugs for Anti-Infective Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Drugs for Anti-Infective Introduction
11.1.4 GlaxoSmithKline Revenue in Drugs for Anti-Infective Business (2019-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Drugs for Anti-Infective Introduction
11.2.4 Merck Revenue in Drugs for Anti-Infective Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Drugs for Anti-Infective Introduction
11.3.4 Pfizer Revenue in Drugs for Anti-Infective Business (2019-2024)
11.3.5 Pfizer Recent Development
11.4 Novartis AG
11.4.1 Novartis AG Company Detail
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Drugs for Anti-Infective Introduction
11.4.4 Novartis AG Revenue in Drugs for Anti-Infective Business (2019-2024)
11.4.5 Novartis AG Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Detail
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Drugs for Anti-Infective Introduction
11.5.4 Gilead Sciences Revenue in Drugs for Anti-Infective Business (2019-2024)
11.5.5 Gilead Sciences Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott Drugs for Anti-Infective Introduction
11.6.4 Abbott Revenue in Drugs for Anti-Infective Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Detail
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Drugs for Anti-Infective Introduction
11.7.4 Sanofi-Aventis Revenue in Drugs for Anti-Infective Business (2019-2024)
11.7.5 Sanofi-Aventis Recent Development
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Detail
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Drugs for Anti-Infective Introduction
11.8.4 Bristol-Myers Squibb Revenue in Drugs for Anti-Infective Business (2019-2024)
11.8.5 Bristol-Myers Squibb Recent Development
11.9 Johnson
11.9.1 Johnson Company Detail
11.9.2 Johnson Business Overview
11.9.3 Johnson Drugs for Anti-Infective Introduction
11.9.4 Johnson Revenue in Drugs for Anti-Infective Business (2019-2024)
11.9.5 Johnson Recent Development
11.10 Roche Pharma AG
11.10.1 Roche Pharma AG Company Detail
11.10.2 Roche Pharma AG Business Overview
11.10.3 Roche Pharma AG Drugs for Anti-Infective Introduction
11.10.4 Roche Pharma AG Revenue in Drugs for Anti-Infective Business (2019-2024)
11.10.5 Roche Pharma AG Recent Development
11.11 Nanosphere
11.11.1 Nanosphere Company Detail
11.11.2 Nanosphere Business Overview
11.11.3 Nanosphere Drugs for Anti-Infective Introduction
11.11.4 Nanosphere Revenue in Drugs for Anti-Infective Business (2019-2024)
11.11.5 Nanosphere Recent Development
11.12 NanoViricides
11.12.1 NanoViricides Company Detail
11.12.2 NanoViricides Business Overview
11.12.3 NanoViricides Drugs for Anti-Infective Introduction
11.12.4 NanoViricides Revenue in Drugs for Anti-Infective Business (2019-2024)
11.12.5 NanoViricides Recent Development
11.13 Novabay Pharmaceuticals
11.13.1 Novabay Pharmaceuticals Company Detail
11.13.2 Novabay Pharmaceuticals Business Overview
11.13.3 Novabay Pharmaceuticals Drugs for Anti-Infective Introduction
11.13.4 Novabay Pharmaceuticals Revenue in Drugs for Anti-Infective Business (2019-2024)
11.13.5 Novabay Pharmaceuticals Recent Development
11.14 Obetech
11.14.1 Obetech Company Detail
11.14.2 Obetech Business Overview
11.14.3 Obetech Drugs for Anti-Infective Introduction
11.14.4 Obetech Revenue in Drugs for Anti-Infective Business (2019-2024)
11.14.5 Obetech Recent Development
11.15 Optimer Pharmaceuticals
11.15.1 Optimer Pharmaceuticals Company Detail
11.15.2 Optimer Pharmaceuticals Business Overview
11.15.3 Optimer Pharmaceuticals Drugs for Anti-Infective Introduction
11.15.4 Optimer Pharmaceuticals Revenue in Drugs for Anti-Infective Business (2019-2024)
11.15.5 Optimer Pharmaceuticals Recent Development
11.16 Basilea Pharmaceutica AG
11.16.1 Basilea Pharmaceutica AG Company Detail
11.16.2 Basilea Pharmaceutica AG Business Overview
11.16.3 Basilea Pharmaceutica AG Drugs for Anti-Infective Introduction
11.16.4 Basilea Pharmaceutica AG Revenue in Drugs for Anti-Infective Business (2019-2024)
11.16.5 Basilea Pharmaceutica AG Recent Development
11.17 Daiichi Sankyo
11.17.1 Daiichi Sankyo Company Detail
11.17.2 Daiichi Sankyo Business Overview
11.17.3 Daiichi Sankyo Drugs for Anti-Infective Introduction
11.17.4 Daiichi Sankyo Revenue in Drugs for Anti-Infective Business (2019-2024)
11.17.5 Daiichi Sankyo Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
